CA
RGEN icon

Crewe Advisors’s Repligen RGEN Stock Holding History

Crewe Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Buy
111
+53
+91% +$6.51K ﹤0.01% 667
2026
Q1 		$6.83K Buy
58
+36
+164% +$5.03K ﹤0.01% 713
2025
Q4 		$3.6K Buy
+22
New +$3.45K ﹤0.01% 786
2024
Q1 		– Sell
-1
Closed -$180 – 994
2023
Q4 		$180 Hold
1
– – ﹤0.01% 358
2023
Q3 		$160 Hold
1
– – ﹤0.01% 466
2023
Q2 		$142 Buy
+1
New +$160 ﹤0.01% 780

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Crewe Advisors's RGEN Position: Q2 2026 in Review

Crewe Advisors increased its Repligen (RGEN) stake by 91% in Q2 2026, buying an estimated $6.51K and bringing the position to 111 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Crewe Advisors first reported a position in RGEN in Q2 2023 and has held it in 6 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Crewe Advisors held 111 shares of Repligen worth $15.1K as of Q2 2026.
  • Crewe Advisors bought 53 Repligen shares in Q2 2026, an estimated $6.51K.
  • Repligen made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #667 holding.
  • Crewe Advisors first reported a position in Repligen in Q2 2023 and has held it in 6 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.